Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer, August 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 168 articles:
HTML format


 

Single Articles

  1. ANDERSSON M, Zewdie BN, Mumena C, Thulin EA, et al
    Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.
    Sci Rep. 2026;16:23719.
    PubMed    
    Abstract available

  2. PANG X, Liu T, Xin J, Li W, et al
    Serotonin transporter acts as a tumor suppressor in cervical cancer.
    Cell Signal. 2026 Jul 31:112771. doi: 10.1016/j.cellsig.2026.112771.
    PubMed    
    Abstract available

  3. SHARMA M, Kumar D, Kumar M, Bassi P, et al
    QbD-driven formulation development and evaluation of apigenin loaded chitosan-tethered in-situ cubosomal gel for the management of cervical cancer: A preclinical study.
    Int J Biol Macromol. 2026 Jul 31:153834. doi: 10.1016/j.ijbiomac.2026.153834.
    PubMed    
    Abstract available

  4. SIULUTA N, Deaterly C, Villalba K, Scaglione NM, et al
    Association of sexual trauma and demographic characteristics with cervical cancer screening among women with HIV.
    AIDS Care. 2026 Jul 31:1-10. doi: 10.1080/09540121.2026.2706231.
    PubMed    
    Abstract available

  5. PRIYANKA B, Gurjar B, Dahiwade S, Narayan G, et al
    Comparative Performance of Pap Smear and Colposcopy in Cervical Cancer Screening Among Women With Abnormal Cervical Findings in Central India: A Prospective Observational Study.
    Health Sci Rep. 2026;9:e72881.
    PubMed    
    Abstract available

  6. ARROYO MUHR LS, Dillner J
    Challenges and possible solutions towards reaching global cervical cancer elimination.
    EClinicalMedicine. 2026;97:103890.
    PubMed    
    Abstract available

  7. KHAN NG, Adiga D, Sanjay KU, Rai PS, et al
    Bisphenol A disrupts mitochondrial homeostasis and promotes metabolic alterations in cervical cancer cells.
    Environ Sci Pollut Res Int. 2026 Jul 30. doi: 10.1007/s11356-026-38082.
    PubMed    
    Abstract available

  8. LIAO L, Zeng L, Zhao Y, Guo Z, et al
    OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer.
    Oncogene. 2026 Jul 30. doi: 10.1038/s41388-026-03909.
    PubMed    
    Abstract available

  9. KOLINA AD, Oleynikova NA, Andreeva YY, Danilova NV, et al
    [The effect of storage duration on the preservation of DNA and the feasibility of genetic studies in formalin-fixed paraffin-embedded tissue samples].
    Arkh Patol. 2026;88:35-40.
    PubMed    
    Abstract available

  10. AHUJA S, Jainar CJE, Moufarrij S, Dee EC, et al
    Global Disparities in Current Clinical Trials in Cervical Cancer.
    JAMA Netw Open. 2026;9:e2626173.
    PubMed    


  11. LUO D, Sharman AR, Bateson D, Smith M, et al
    Gynaecologists' Views and Acceptability of Active Surveillance for Women Diagnosed With Cervical Intraepithelial Neoplasia 2: A Qualitative Study.
    Aust N Z J Obstet Gynaecol. 2026;66:e70165.
    PubMed    
    Abstract available

  12. HUANG H, Li P, Zhu L, Wu Y, et al
    RNA-Binding Protein RBMS3 Inhibits Cervical Cancer Progression by Enhancing HSPA6 mRNA Stability.
    Front Biosci (Landmark Ed). 2026;31:51761.
    PubMed    
    Abstract available

  13. MBELWA H, Leo J, Kahesa C, Munema A, et al
    BiCervi: Pap smear microscopy image dataset for cervical cancer detection and classification.
    Data Brief. 2026;68:113077.
    PubMed    
    Abstract available

  14. HUANG L, Lin N, Li H, Hu Y, et al
    Spatially organized macrophage-T-cell crosstalk in cervical cancer: insights from single-cell and spatial omics.
    Front Immunol. 2026;17:1896004.
    PubMed    
    Abstract available

  15. CURRIER JJ, Van Houweling E, Bolten K, Wasson N, et al
    Female allogeneic hematopoietic cell transplant survivors' perspectives on cervical cancer screening: a retrospective study.
    Support Care Cancer. 2026;34:814.
    PubMed    
    Abstract available

  16. POLTEN R, Kutle I, Stalp JL, Hachenberg J, et al
    Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.
    Sci Rep. 2026;16:23557.
    PubMed    
    Abstract available

  17. YANG H, Yang W, Tian H, Chang Y, et al
    Multi-modal Stacking Machine Learning Model for Predicting Lymph Node Metastasis in Cervical Cancer.
    Acad Radiol. 2026 Jul 29:S1076-6332(26)00530-1. doi: 10.1016/j.acra.2026.
    PubMed    
    Abstract available

  18. WU N, Lin F, Ji J, Pan H, et al
    Retraction notice to "Mitochondrial oxidative stress related LncRNA predict cervical cancer prognosis and immunotherapy response: Molecular structure and protein interaction of ribosomal protein L34" [Int. J. Biol. Macromol. 299 (2025) 140145].
    Int J Biol Macromol. 2026 Jul 29:153730. doi: 10.1016/j.ijbiomac.2026.153730.
    PubMed    


  19. SCHRODER C, Qureischi M, Hecking T, Nadal J, et al
    Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer.
    Anticancer Res. 2026;46:4371-4383.
    PubMed    
    Abstract available

  20. WILSON A, Cropper A, Ma Y, Adams EJ, et al
    Improving laboratory workforce efficiency using AI-assisted digital cytology within an HPV-based cervical screening programme: A model-based evaluation for the NHS Cervical Screening Programmes.
    BMJ Open. 2026;16:e113298.
    PubMed    
    Abstract available

  21. MIN S, Zhu Y, Xie L, Zhang H, et al
    TCTP regulates the infiltration of CXCR4+ immunosuppressive cells in cervical Cancer via the non-canonical NF-kappaB/ZEB1/CXCL12 Axis.
    Cell Signal. 2026 Jul 29:112761. doi: 10.1016/j.cellsig.2026.112761.
    PubMed    
    Abstract available

  22. ZHANG P, Tong X, Chen X, Feng Y, et al
    Changes in HPV vaccine hesitancy and influencing factors among female university students in China: A national repeated study.
    Hum Vaccin Immunother. 2026;22:2701549.
    PubMed    
    Abstract available

  23. SWISHER EM, Davis M, Rubin-Saika M, Manhardt E, et al
    Cervical Cancer Screening With Human Papillomavirus Self-Collection Testing in an Opioid Treatment Program.
    JAMA Netw Open. 2026;9:e2625993.
    PubMed    
    Abstract available

  24. ZHENG X, Wang W, He C, Wang L, et al
    LncRNA DNM3OS suppresses proliferation, invasion, and epithelial-mesenchymal transition in cervical cancer cells via miR-454-3p.
    Mol Biol Rep. 2026;53:1300.
    PubMed    
    Abstract available

  25. SILVA ERPHD, Gubert VT, Puga MAM, Tozetti IA, et al
    Cervical cancer screening in incarcerated women: deprived of freedom or deprived of health?
    Rev Bras Enferm. 2026;79:e20250011.
    PubMed    
    Abstract available

  26. CHANG H, Liu X, Qin L, Wang Y, et al
    An explainable machine learning approach for cervical cancer screening: decoding morphological diagnostic drivers.
    Acta Clin Belg. 2026 Jul 29:1-13. doi: 10.1080/17843286.2026.2711062.
    PubMed    
    Abstract available

  27. UTAMI TW, Nuranna L, Purwoto G, Oktalia A, et al
    Unveiling Optimal Cervical Cancer Screening Age Range: Study of HPV Infection Among 75,719 Women in Indonesia's Metropolitan Regions (2012 - 2022).
    Asian Pac J Cancer Prev. 2026;27:2541-2548.
    PubMed    
    Abstract available

  28. KAUR SD, Dwivedi R, Nalwa A, Dwivedi P, et al
    Awareness of and Barriers to Cervical Cancer Screening among Married Tribal Women in Sirohi, Rajasthan: A Community-based Study.
    Asian Pac J Cancer Prev. 2026;27:2457-2465.
    PubMed    
    Abstract available

  29. CHEN Y, Xie Y, Wu J, Qu X, et al
    Mucus and tumor penetrating paclitaxel micelles for potent local therapy of cervical cancer.
    J Nanobiotechnology. 2026;24:700.
    PubMed    
    Abstract available

  30. OGURA J, Sato S, Koshida Y, Kasuga M, et al
    HPV18-Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights.
    J Obstet Gynaecol Res. 2026;52:e70426.
    PubMed    
    Abstract available

  31. DALABEHERA M, Chaudhari S, Kumar J, Poonia N, et al
    Mechanistic advances in nanomedicine, nucleic acid therapies, and AI-driven research on cervical cancer.
    J Pharm Sci. 2026 Jul 28:104442. doi: 10.1016/j.xphs.2026.104442.
    PubMed    
    Abstract available

  32. ZHANG M, Wang N, Liu X, Wang Y, et al
    STING-engineered biomimetic hybrid membrane nanovaccine for enhanced immunotherapy of cervical cancer.
    Colloids Surf B Biointerfaces. 2026;268.
    PubMed    
    Abstract available

  33. XIAO C, Huang C, Lin W, Tian F, et al
    Improving CT-CBCT deformable image registration for cervical cancer adaptive radiotherapy using a deep learning approach.
    Front Oncol. 2026;16:1855718.
    PubMed    
    Abstract available

  34. GUIMARAES JMN, Pescarini JM, Moncayo AL, Craig P, et al
    Racial inequities in cervical cancer mortality and the role of the Bolsa Familia conditional cash transfer programme: results from the 100 Million Brazilian Cohort.
    Lancet Reg Health Am. 2026;62:101562.
    PubMed    
    Abstract available

  35. KOLAMBKAR S, Tomar M, Arif N, Hussain S, et al
    HPV vaccination in the WHO South-East Asia Region: A scoping review of uptake, implementation challenges, and pathways to acceleration.
    Hum Vaccin Immunother. 2026;22:2693359.
    PubMed    
    Abstract available

  36. YILIHAMU Y, Zhang X, Zhao Z, Aili M, et al
    Tumor microenvironment-activated HA@GOx/IR-820@MnO(2) nanosheets for dual-modal imaging guided phototherapy of cervical cancer.
    J Mater Chem B. 2026 Jul 28. doi: 10.1039/d6tb01062.
    PubMed    
    Abstract available

  37. GONCALVES E, Fontes F, Rodrigues JR, Calisto R, et al
    Second primary cancers among females with a first primary cervical, uterine and ovarian cancer: a population-based study in North Portugal.
    Cancer Causes Control. 2026;37:136.
    PubMed    
    Abstract available

  38. ADEFOLALU AO
    Cervical Cancer Screening in Women Living with HIV in South Africa: Addressing Health Disparities Through Integrated Prevention Strategies.
    Int J Womens Health. 2026;18:613391.
    PubMed    
    Abstract available

  39. LUVIAN-MORALES J, Rueda-Escalona AA, Delgadillo-Gonzalez M, Cetina-Perez LDC, et al
    Benefits of an anti-inflammatory diet compared to a low-residue diet during concurrent chemoradiation therapy for patients with locally advanced cervical cancer: a randomized clinical trial.
    Front Nutr. 2026;13:1835417.
    PubMed    
    Abstract available

  40. DOU Z, Yu S, Zhang J, Wu X, et al
    Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study.
    Front Oncol. 2026;16:1826692.
    PubMed    
    Abstract available

  41. WANG W, Li X, Jiang Y, Lu Y, et al
    Non-contrast MRI Radiomics Nomogram for Predicting Recurrence and Progression-Free Survival in Cervical Cancer following Concurrent Chemoradiotherapy.
    Curr Med Imaging. 2026 Jul 23. doi: 10.2174/0115734056449836260717192214.
    PubMed    
    Abstract available

  42. SORBYE SW, Falang BM, Antonsen M, Richardsen E, et al
    Genotype-Specific HPV E6/E7 mRNA Triage for Risk Stratification in HPV DNA-Positive Women with ASC-US/LSIL: A Population-Based Tromso Cohort.
    Pathogens. 2026;15:747.
    PubMed    
    Abstract available

  43. SAYER TG, Yilmaz G, Ozdemir F
    Cisplatin and epsilon-Viniferin Synergistically Modulate Oxidative Stress in HeLa Cells: Implications for Redox Modulation in Cervical Cancer Cells.
    Molecules. 2026;31:2409.
    PubMed    
    Abstract available

  44. CORTES J, Nassar N, Blasco MDR, Castano R, et al
    Rapid Systematic Review-Informed Multidisciplinary Expert Consensus on the Management of HPV-Positive Women with Low-Grade Cervical Lesions and the Role of a Coriolus versicolor-Based Vaginal Treatment.
    Medicina (Kaunas). 2026;62:1283.
    PubMed    
    Abstract available

  45. UCAR M, Yigit MF, Kartal SA, Yagan A, et al
    Effect of a Health Belief Model Based Education Program on Women's Cervical Cancer Knowledge and HPV Vaccination Attitudes in Primary Care Settings.
    Healthcare (Basel). 2026;14:2118.
    PubMed    
    Abstract available

  46. EBNER C, Ebner L, Skvortsov S, Fiegl H, et al
    Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study.
    Cancers (Basel). 2026;18:2225.
    PubMed    
    Abstract available

  47. DRUMOND HC, Silvestrini MMA, Dos Santos LM, Magalhaes-Gama F, et al
    Elevated Circulating Extracellular Vesicles as Prognostic Biomarkers in Cervical Cancer Progression.
    Biomedicines. 2026;14:1492.
    PubMed    
    Abstract available

  48. SANTOS F, Silva MS, Caramelo FA, Santana MM, et al
    Cell-Free DNA Fragmentation Patterns as Biomarkers for Human Papillomavirus-Related Cancers: A Systematic Review of Methodological Diversity and Diagnostic Performance.
    Int J Mol Sci. 2026;27:6372.
    PubMed    
    Abstract available

  49. SUN Q, Wang D, Zhao Q, Cui Y, et al
    PET117 Deficiency Confers Ferroptosis Resistance Through ACSF2 Downregulation in Cervical Cancer.
    Antioxidants (Basel). 2026;15:876.
    PubMed    
    Abstract available

  50. DE MELO NETO AB, Queiroz FR, de Souza Melo CP, Duarte BCD, et al
    ATF4, ZIK1, and PNMA3 Transcriptomic Signatures Predict Chemoradiotherapy Response in Cervical Cancer.
    Cancer Med. 2026;15:e72053.
    PubMed    
    Abstract available

  51. NG XR, Quek IP, Pereira MJ, Molina JA, et al
    Effect of Self-Sampling HPV DNA Testing on Cervical Cancer Screening in Singapore's Primary Care: Pragmatic Randomized Controlled Trial.
    Ann Fam Med. 2026;24:291-300.
    PubMed    
    Abstract available

  52. JOHANSEN ME, Ihongbe TO, McClain M
    Annals Journal Club: HPV Self-Sampling vs Clinician Sampling for Cervical Cancer Screening.
    Ann Fam Med. 2026;24:381.
    PubMed    


  53. KATARIA B, Mukhopadhyay A, Oaknin A, O'Donnell DM, et al
    Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.
    Lancet Oncol. 2026;27:e379-e391.
    PubMed    
    Abstract available

  54. ALCAZAR JL, Espinosa F, de la Maza F, Opazo MP, et al
    Role of three-dimensional ultrasound in the diagnosis and staging of gynecological malignancies: Focus on endometrial and cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2026;108:102758.
    PubMed    
    Abstract available

  55. JIA J, Wang L, Wang F
    Considerations for the Clinical Translation of Low-Dose Computed Tomography-Based Plan-Pool Adaptive Radiotherapy in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;57:104284.
    PubMed    


  56. NAVYA VB, Muraleedharan G, Fasna PK, Kumar R, et al
    A prognostic immune signaling-related lncRNA-circRNA-mRNA network model for cervical cancer using machine learning.
    Biochem Biophys Res Commun. 2026;831:154337.
    PubMed    
    Abstract available

  57. QIAN L, Li Y, Zheng J, Liang T, et al
    GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer.
    Cell Rep. 2026;45:117704.
    PubMed    
    Abstract available

  58. LI Z, Tang L, Wang M, Yu Q, et al
    beta-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells.
    J Biochem Mol Toxicol. 2026;40:e71032.
    PubMed    
    Abstract available

  59. ORTEGA-AGUIRRE MF, Olivas-Armendariz I, Silva-Espinoza JC, Hernandez-Gonzalez ME, et al
    Characterization of Hydrogels of Gelatin/O-Carboxymethyl Chitosan in Ovule Form with Curcumin and Retinyl Palmitate as a Treatment for Cervical Cancer.
    Gels. 2026;12:618.
    PubMed    
    Abstract available

  60. XU T, Ke J, Yue Y, Zhu Z, et al
    The Efficacy of Transcutaneous Electrical Acupoint Stimulation as an Adjunct to Standard Bladder Training for Bladder Emptying After Radical Hysterectomy for Cervical Cancer: A Randomized Controlled Trial.
    Curr Oncol. 2026;33:424.
    PubMed    
    Abstract available

  61. HEWAPATHIRANAGE-MAYADUNNE H, Bergeron E, Kushalnagar P
    Rethinking Communication Barriers: Educational Attainment in Cervical Cancer Screening Among American Sign Language Users.
    Eur J Investig Health Psychol Educ. 2026;16:97.
    PubMed    
    Abstract available

  62. KASE S, Zimmermann ML, Magi M, Baburin A, et al
    Changing burden of cancers related to human papillomavirus in Estonia: a population-based registry study.
    Acta Oncol. 2026;65:632-640.
    PubMed    
    Abstract available

  63. VISHNOI MG, Jain A, Akhariya R, Balaan V, et al
    Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators - a prospective study with paradigm-shifting clinical implications.
    Nucl Med Rev Cent East Eur. 2026;29:e00626007.
    PubMed    
    Abstract available

  64. BARUWA OJ, Singini MG, Gwebu H, Nduka CC, et al
    Accelerating cervical cancer elimination: healthcare decision-making and cervical cancer screening uptake in sub-Saharan Africa.
    Prev Med Rep. 2026;69:103572.
    PubMed    
    Abstract available

  65. ABDUL KARIM SIDDIQUE F, de Zeeuw J, Koot JAR, Nakisige C, et al
    Effectiveness of community-based culturally tailored cervical cancer awareness interventions among women and decision-making men in low-resource settings: A pre-post design evaluation in rural Uganda and Bangladesh.
    Prev Med Rep. 2026;69:103575.
    PubMed    
    Abstract available

  66. CAI Z, Liu D, He Y, Fang Z, et al
    Stichopus japonicus acidic mucopolysaccharide (SJAMP) exerts the tumor-suppressive activity in cervical cancer by targeting TFAP2A to downregulate CENPW.
    Cytotechnology. 2026;78:165.
    PubMed    
    Abstract available

  67. ARIMOTO T, Kasamatsu T, Machida R, Toita T, et al
    A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).
    J Gynecol Oncol. 2026 Jul 13. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  68. YIN X, Tian X, Huang C, Xiang S, et al
    Exploratory preoperative assessment of lymphovascular space invasion in cervical cancer: comparative insights from intravoxel incoherent motion and diffusion-relaxation correlation spectrum imaging.
    Br J Radiol. 2026 Jul 25:tqag169. doi: 10.1093.
    PubMed    
    Abstract available

  69. ARYA K, Tiwari R, Singh V, Sukla P, et al
    Assessment of Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Its Vaccine Among Adolescent Girls at an Urban Health Training Center in Chhallapura, Datia, Madhya Pradesh: A Community-Based Study.
    Cureus. 2026;18:e111412.
    PubMed    
    Abstract available

  70. PENG C, Liang C, Liu J, Liu Y, et al
    Small RNA sequencing identifies tsRNA-05020 as a potential regulator of cervical cancer progression.
    Turk J Biol. 2026;50:197-208.
    PubMed    
    Abstract available


  71. Retraction: miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
    Oncol Res. 2026;34:31.
    PubMed    
    Abstract available

  72. THOBIAS AR, Patel KA, Mehta KA, Patel BM, et al
    Transcriptional Scenario of Altered Glycosylation in HPV-Associated Cervical Cancer.
    Indian J Clin Biochem. 2026;41:598-605.
    PubMed    
    Abstract available

  73. BAHADUR B, Choudhary S, Oswal D, Singh T, et al
    Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India.
    Front Oncol. 2026;16:1872738.
    PubMed    
    Abstract available

  74. LUO Y, Xie XH, Huang XQ, Hu HQ, et al
    A prognostic signature based on methionine metabolism-related genes for cervical cancer: integrated transcriptomic and experimental validation.
    PeerJ. 2026;14:e21538.
    PubMed    
    Abstract available

  75. GRILLO N, Almendra R, Correia C
    Assessment of the impact of nonavalent human papillomavirus vaccine on disease clearance time in women with active infection.
    Rev Bras Ginecol Obstet. 2026;48:e-rbgo17.
    PubMed    
    Abstract available

  76. SINGH K, Grover A, Dhanasekaran K
    Cascade strengthening and test choice are complementary, not competing in Indian cervical cancer screening.
    Glob Epidemiol. 2026;12:100277.
    PubMed    


  77. DOYLE CM, Ronn MM, van Schalkwyk C, Brisson M, et al
    Potential Impact of Catch-Up HPV Vaccination on HPV Prevalence and Cervical Cancer Incidence Among Women Living With HIV in South Africa: Results From Two Mathematical Models.
    J Int AIDS Soc. 2026;29 Suppl 2.
    PubMed    
    Abstract available

  78. PETER O, Oborevwori E, Osagie E, Akhigbe P, et al
    From Awareness to Action Study: Improving Human Papillomavirus Knowledge, Screening and Vaccine Uptake Among Mother-Adolescent Pairs in the HOMINY Study in Nigeria: A Longitudinal Study.
    J Int AIDS Soc. 2026;29 Suppl 2.
    PubMed    
    Abstract available

  79. IKEDA S, Kawaguchi S, Baba K, Takahashi H, et al
    Salvage tacrolimus therapy for steroid-refractory immune-related adverse event-associated sclerosing cholangitis.
    Clin J Gastroenterol. 2026;19:1003-1007.
    PubMed    
    Abstract available

  80. JOPS P, Wolter A, Bavor C, Dodd R, et al
    Qualitative insights into the acceptability of self-collection for cervical screening amongst under- and never-screened groups in Australia.
    BMC Public Health. 2026;26:2242.
    PubMed    
    Abstract available

  81. MONTI E, Monti C, Matozzo CMM, Salmaso M, et al
    The 'see-and-treat' approach in the treatment of preneoplastic cervical lesions.
    Eur J Cancer Prev. 2026;35:465-472.
    PubMed    
    Abstract available

  82. DEJENE K
    Navigating stigma, faith, and fear: understanding HPV vaccine acceptance among adolescent girls in rural parts of Central Ethiopia.
    Cult Health Sex. 2026;28:978-989.
    PubMed    
    Abstract available

  83. ZHU G, Piao Z, Gao Y, Cong X, et al
    Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1alpha-SIX1 axis.
    iScience. 2026;29:117007.
    PubMed    
    Abstract available

  84. SUVVARI TK
    Turning the Tide on Cervical Cancer in India.
    Clin Med Insights Oncol. 2026;20:11795549261471277.
    PubMed    


  85. ZHANG T, Fan W, Liu K, Xu H, et al
    Time-dependent diffusion MRI for assessing tumor microstructure and prognostic risk factors in cervical cancer.
    Abdom Radiol (NY). 2026 Aug 8. doi: 10.1007/s00261-026-05703.
    PubMed    
    Abstract available

  86. KEBEDE FB, Mare KU, Arage FG, Tiyou A, et al
    Predicting lifetime cervical cancer screening among sexually active women in low- and middle-income countries using machine learning models: evidence from Demographic and Health Surveys.
    AJOG Glob Rep. 2026;6:100669.
    PubMed    
    Abstract available

  87. BEJARANO-HERNANDEZ L, Chan A, Gosalia M, Moore M, et al
    Expanding HPV prevention across the life course: evidence on vaccine effectiveness in adults.
    Front Public Health. 2026;14:1894760.
    PubMed    
    Abstract available

  88. GUO Q, Xu C, Li J, Qi C, et al
    COVID-19 vaccination rates as a proxy for health system resilience: implications of development disparities for cervical cancer control during the pandemic.
    Front Med (Lausanne). 2026;13:1858206.
    PubMed    
    Abstract available

  89. HUANG H, Liu L, Cui Y, Zhou F, et al
    Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming.
    Front Immunol. 2026;17:1848357.
    PubMed    
    Abstract available

  90. WANG X, Na J, Wang Y, Han B, et al
    Initial clinical experience with total Mullerian compartment resection for locally advanced cervical cancer: a single-center preliminary retrospective cohort study and learning-curve analysis.
    Front Oncol. 2026;16:1865445.
    PubMed    
    Abstract available

  91. ZHANG J, Chen C, Song H, Li D, et al
    NTMT1 (METTL11A) promotes MYC-dependent proliferation and downstream HLA-A suppression in cervical cancer.
    Front Immunol. 2026;17:1853434.
    PubMed    
    Abstract available

  92. FAUZIA RP, Rahmani AA, Putri RA, Haryuni RD, et al
    Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.
    Sci Rep. 2026;16:24462.
    PubMed    
    Abstract available

  93. ACQUAH-HAGAN G, Boateng D, Boakye K, Idan JS, et al
    Family and sexual functioning among women diagnosed with cervical cancer in Urban Ghana: A mixed-methods study.
    Womens Health (Lond). 2026;22:17455057261476899.
    PubMed    
    Abstract available

  94. TANAKA S, Yamamoto Y, Yokota K, Yamamoto T, et al
    Diagnostic performance of artificial intelligence models trained on scattered single-cell images is not preserved for hyperchromatic crowded cell groups in cervical cytology.
    Cancer Cytopathol. 2026;134:e70140.
    PubMed    
    Abstract available

  95. FENG X, He L, Gao Y, Qiu Y, et al
    Efficacy and safety of a combination of monoclonal antibodies and chemoradiotherapy for the treatment of locally advanced cervical cancer in Chinese patients: a systematic review and meta-analysis.
    Int J Radiat Biol. 2026 Aug 7:1-16. doi: 10.1080/09553002.2026.2710755.
    PubMed    
    Abstract available

  96. LI BY, Fan T, Chen JY, Zhang YH, et al
    Internal feasibility evaluation of SAM-Med3D for cervical cancer clinical target volume segmentation on planning computed tomography.
    Radiol Phys Technol. 2026 Aug 7. doi: 10.1007/s12194-026-01092.
    PubMed    
    Abstract available

  97. LI X, Pan S, Qu P, Wu D, et al
    Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021.
    J Gynecol Oncol. 2026 Jul 31. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  98. YOON HY, Jeon HS, Kim MJ, Kim JM, et al
    Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening.
    J Low Genit Tract Dis. 2026 Aug 7. doi: 10.1097/LGT.0000000000000976.
    PubMed    
    Abstract available

  99. JAISWAL A, Goyal P, Kumari S, Aggarwal D, et al
    Cervical cancer awareness and vaccine hesitancy with respect to HPV vaccination in urban community of Faridabad, Haryana, India.
    Clin Exp Vaccine Res. 2026;15:209-215.
    PubMed    
    Abstract available

  100. ARYANPOUR M, Abolghasemi J, Moghadam SMK
    Psychosocial predictors of cervical cancer screening intention among female teachers in Karaj, Iran: An integrated behavioral model.
    Prev Med Rep. 2026;69:103589.
    PubMed    
    Abstract available

  101. WEI L, Menghui H, Dandan Z, Xin W, et al
    HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products.
    Front Immunol. 2026;17:1892919.
    PubMed    
    Abstract available

  102. PROMTHONG C, Navakanitworakul R, Obaun K, Hanprasertpong J, et al
    Association between Urinary-Extracellular-Vesicle-Enriched Proteome Dynamics and Oncological Outcomes Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer.
    Comput Struct Biotechnol J. 2026;35:0196.
    PubMed    
    Abstract available

  103. HUANG C, Zhang W, Ma X, Li X, et al
    Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling.
    Mol Genet Genomics. 2026;301:165.
    PubMed    
    Abstract available

  104. UCOK BS, Kinay T, Kusabbi IA, Dereli ML, et al
    The association of total oxidant status, total antioxidant status, and ischemia-modified albumin levels with cervical human papillomavirus infection and cervical intraepithelial neoplasia.
    Rev Assoc Med Bras (1992). 2026;72:e20252260.
    PubMed    
    Abstract available

  105. BINTABARA D, Kamata CC, Mohamedi R, Konje E, et al
    Regional variations and predictors of low uptake of cervical cancer screening among women aged 30-49 years in Tanzania: a geospatial and multilevel analysis of population-based survey.
    Res Health Serv Reg. 2026;5:11.
    PubMed    
    Abstract available

  106. KUL KOPRULU T, Erkal Cam B
    Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.
    J Bioenerg Biomembr. 2026;58:45.
    PubMed    
    Abstract available

  107. MA X, Li Y, Yi S, Chen X, et al
    Time-dependent diffusion MRI for differentiating cervical cancer subtypes: impact of ROI delineation strategies on diagnostic performance.
    Abdom Radiol (NY). 2026 Aug 6. doi: 10.1007/s00261-026-05721.
    PubMed    
    Abstract available

  108. KISHIMOTO Y, Sasaki M, Otsuka H, Kubo A, et al
    Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer.
    J Radiat Res. 2026 Aug 6:rrag060. doi: 10.1093.
    PubMed    
    Abstract available

  109. HOU H, Zhang L, Li C, Liu M, et al
    Plasma HPV ctDNA as a dynamic biomarker for treatment response and prognosis in locally advanced cervical cancer: protocol for a prospective cohort study.
    Front Oncol. 2026;16:1844938.
    PubMed    
    Abstract available

  110. LI Z, Duan Z, Liu R, Yu S, et al
    Morphology-defined bacterial vaginosis and HPV-related cervical screening abnormalities: a two-year real-world study with histopathologic correlation.
    Front Cell Infect Microbiol. 2026;16:1890650.
    PubMed    
    Abstract available

  111. QIU L, Li Y, Wang Y, Xie Y, et al
    Higher pre-treatment lymphocyte-to-monocyte ratio predicts better tumor shrinkage after external beam radiotherapy in locally advanced cervical cancer.
    Front Oncol. 2026;16:1917302.
    PubMed    
    Abstract available

  112. RAHAL ADAWI N, Ben Shachar I
    Ethnic Disparity in Cervical Cancer Stage at Diagnosis at a Tertiary Medical Center in Northern Israel: A Retrospective Study.
    Isr Med Assoc J. 2026;28:433-437.
    PubMed    
    Abstract available

  113. SHAH K, Du C, Akgul A, Alshammari FS, et al
    Modelling the impact of awareness campaigns on HPV transmission dynamics: a neural network-enhanced mathematical model.
    Sci Rep. 2026;16:24277.
    PubMed    
    Abstract available

  114. AWAN UA, Zafar N, Khan S
    Infodemic preparedness and the 90-70-90 cervical cancer targets.
    Lancet Digit Health. 2026 Aug 5:101079. doi: 10.1016/j.landig.2026.101079.
    PubMed    


  115. AFTABSAVAD S, Arashkia A, Shokrgozar MA, Rahimi AA, et al
    mRNA vaccines targeting HPV E6/E7: A new frontier in cervical cancer immunotherapy.
    Crit Rev Oncol Hematol. 2026;226:105520.
    PubMed    
    Abstract available

  116. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
    Invasive Cervical Cancer Detection After Transition to Primary Human Papillomavirus Screening: Population-Based Linkage Study in Portugal.
    Acta Med Port. 2026;39:438-447.
    PubMed    
    Abstract available

  117. WATSON JL
    The Cancer That Could Disappear.
    Clin J Oncol Nurs. 2026;30:252-253.
    PubMed    
    Abstract available

  118. QIN H, Yang N, Wang Q, Tian L, et al
    Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.
    Acta Oncol. 2026;65:689-701.
    PubMed    
    Abstract available

  119. RENZAHO AMN, Challam S, Hartcher N, Smith M, et al
    Co-Designing Culturally Tailored Bowel, Cervical and Breast Cancer Screening Interventions With Migrant Communities: Towards Closing the Migration-Related Cancer-Equity Gap in New South Wales, Australia.
    Health Expect. 2026;29:e70805.
    PubMed    
    Abstract available

  120. CHEBAT A, Pharoun J, Rachid M, Bazzi M, et al
    Prevalence and Determinants of Knowledge and Attitudes Toward Cervical Cancer Prevention, Pap Smear Uptake, and Human Papilloma Virus Vaccination Among Lebanese Women.
    Womens Health Rep (New Rochelle). 2026;7:26884844261437618.
    PubMed    
    Abstract available

  121. LOU H, Zhou Y, Li D, Zhang H, et al
    Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
    Cell Rep Med. 2026 Aug 4:102944. doi: 10.1016/j.xcrm.2026.102944.
    PubMed    
    Abstract available

  122. MI J, Guo W, Li L, Wang S, et al
    Single-cell transcriptomics uncovers HPV-driven immune evasion and establishes a TAB2-based prognostic signature in cervical cancer.
    Transl Oncol. 2026;72:102935.
    PubMed    
    Abstract available

  123. JALINK M, King WD, Booth CM, Gien LT, et al
    The diagnosis to surgery interval and overall survival in patients with cervical cancer.
    Cancer Epidemiol. 2026;104:103190.
    PubMed    
    Abstract available

  124. FUKUNAGA C, Hiranuma K, Hirayama T, Yoshida E, et al
    Right Ventricular Metastasis From Cervical Cancer Treated With Pembrolizumab-Containing Chemotherapy: A Case Report and Literature Review.
    Am J Case Rep. 2026;27:e952931.
    PubMed    
    Abstract available

  125. BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
    Correction: Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
    Front Oncol. 2026;16:1929623.
    PubMed    
    Abstract available

  126. CAMPANHA NOVAES LA, Oliveira RD, Tegami IL, Santiago Goncalves MF, et al
    Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.
    iScience. 2026;29:116758.
    PubMed    
    Abstract available

  127. HSIAO KY, Lin HL, Chen CC
    Diagnostic Performance of HPV Testing Using Self-Collected Urine and Vaginal Samples for Detecting Cervical Precancer or Worse: A Meta-Analysis.
    J Obstet Gynaecol Res. 2026;52:e70434.
    PubMed    
    Abstract available

  128. YIGIT E, Gultekin M, Bayatfard P, Yuce Sari S, et al
    The impact of uterine position during brachytherapy on treatment outcomes and toxicity in patients with cervical cancer.
    Strahlenther Onkol. 2026 Aug 3. doi: 10.1007/s00066-026-02582.
    PubMed    
    Abstract available

  129. DONG F, Chen D, Shang JF, Fang W, et al
    [Diagnostic efficacy and teaching value of artificial intelligence-assisted diagnostic systems in cervical liquid-based cytology screening].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:744-751.
    PubMed    
    Abstract available

  130. TEBEJE TM, Metkie KA, Asgedom YS, Gebrekidan AY, et al
    Magnitude of human papillomavirus vaccination uptake and its determinants among adolescent girls in Lesotho: a cross-sectional study.
    BMJ Open. 2026;16:e110615.
    PubMed    
    Abstract available

  131. LYNN T, Sychareun V, Chaleunvong K, Vongxay V, et al
    Integrated service delivery to improve adolescent health and human papillomavirus (HPV) vaccination in Lao PDR: a quasi-experimental mixed-methods study - study protocol.
    BMJ Open. 2026;16:e098836.
    PubMed    
    Abstract available

  132. XIAO Y, Yang L, Yu X, Cheng HJ, et al
    Efficacy and Safety of Camrelizumab Combined with Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Phase II Single-Arm Clinical Trial.
    Clin Oncol (R Coll Radiol). 2026;57:104293.
    PubMed    
    Abstract available

  133. JINDAL R, R R, Ghanghas N, Gupta R, et al
    Addressing HPV vaccine hesitancy and misinformation in India through public health communication strategies.
    Hum Vaccin Immunother. 2026;22:2711551.
    PubMed    
    Abstract available

  134. LIU SQ, Cheng XX, He S, Xia T, et al
    Corrigendum to Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.
    J Clin Invest. 2026;136:e209744.
    PubMed    


  135. LIU L, Du X, Zhao Y, Chen H, et al
    Cost-Related Barriers, Mental Distress, and Cervical Cancer Screening Adherence: A BRFSS 2024 Analysis.
    J Prim Care Community Health. 2026;17:21501319261475712.
    PubMed    
    Abstract available

  136. ADAM J, Mukuku O, Maseb'a Mwang Sulu S, Nsambi JB, et al
    Factors Associated With Cervical Cancer Awareness Among Women of Reproductive Age in the Democratic Republic of the Congo: Evidence From a Nationwide DHS Analysis.
    Cancer Rep (Hoboken). 2026;9:e70633.
    PubMed    
    Abstract available

  137. DOWOU RK, Salu S, Takyiwaa JA, Aboagye RG, et al
    Residency-Based Inequalities in Cervical Cancer Screening in Sub-Saharan Africa.
    Trop Med Int Health. 2026 Aug 2. doi: 10.1111/tmi.70152.
    PubMed    
    Abstract available

  138. SCHLEICHER OM, Dietl AK, Behrens AS, Brueckner L, et al
    Regression of high-grade squamous intraepithelial lesions in women aged 30 years or younger: a retrospective cohort study.
    J Cancer Res Clin Oncol. 2026;152:152.
    PubMed    
    Abstract available

  139. MAEDA M, Kitai M, Akada M, Shimizu Y, et al
    Preoperative prediction of the need for postoperative adjuvant therapy in stage IB cervical cancer using tumor size measured on magnetic resonance imaging and serum squamous cell carcinoma antigen levels.
    AJOG Glob Rep. 2026;6:100671.
    PubMed    
    Abstract available

  140. SOLIMAN S, Thomas T, Barker V, Aboujaoude M, et al
    Association of Increased MIEN1 Copy Number With Worse Outcomes in Lung Adenocarcinoma and Cervical Cancer.
    Cureus. 2026;18:e111880.
    PubMed    
    Abstract available

  141. OLUMODEJI AM, Adefemi AK, Adedeji MO, Edun OQ, et al
    RADICAL HYSTERECTOMY FOR EARLY-STAGE CERVICAL CANCER IN A LOWRESOURCE SETTING: SURGICAL OUTCOMES AND LESSONS FROM A RETROSPECTIVE CROSS-SECTIONAL STUDY.
    Ann Ib Postgrad Med. 2026;24:39-45.
    PubMed    
    Abstract available

  142. CHEN Y, Wang L, Li S, Huang J, et al
    Cross-scale modeling reveals a TFRC-driven immunosuppressive macrophage niche in cervical cancer.
    Front Immunol. 2026;17:1872944.
    PubMed    
    Abstract available

  143. VERGALASOVA I, Jiang C, Song T, Lombe D, et al
    Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration.
    Front Oncol. 2026;16:1872192.
    PubMed    


  144. GONZALEZ GMN, Msadabwe S, Njala B, Sakala D, et al
    Prior Cervical Cancer Screening, Social Determinants of Health, and HIV Status Among Patients at the Cancer Disease Hospital, Zambia.
    Res Sq [Preprint]. 2026 Jul 22:rs.3.rs-10345811.
    PubMed    
    Abstract available

  145. BHAT S, Devi V, Kabekkodu SP
    In silico analysis of driver genes in squamous cell carcinoma of the cervix: insights into their biological functions, prognosis, immune infiltration, and therapy.
    World J Surg Oncol. 2026;24:324.
    PubMed    
    Abstract available

  146. ABUH SO, Barbora A, Nave V, Ben-Arie A, et al
    Attenuated total reflection Fourier transform infrared spectroscopy enables determination of the extent of precancer in cervical conization biopsy.
    Sci Rep. 2026;16:24132.
    PubMed    
    Abstract available

  147. DU M, Wei L, Geng M, Wang W, et al
    Cervical microbial dysbiosis in single HPV16-positive HSIL.
    Sci Rep. 2026;16:23893.
    PubMed    
    Abstract available

  148. MARCADET J, Ayadi S, Mal PA
    When pelvic actinomycosis mimics cervical neoplasia: A diagnostic challenge.
    J Gynecol Obstet Hum Reprod. 2026;55:103222.
    PubMed    
    Abstract available

  149. LI N, Hu Y, van der Zee AGJ, Schuuring E, et al
    PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1411-1420.
    PubMed    
    Abstract available

  150. CHENG J, Yuan H, Su M
    Pleural Metastasis as the Only Presentation of Recurrent Cervical Carcinoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006545.
    PubMed    
    Abstract available

  151. GUONA Z, Yabin S, Qian D, Yang L, et al
    Mixed Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Cervix: A Rare Entity.
    Int J Surg Pathol. 2026;34:1616-1622.
    PubMed    
    Abstract available

  152. BADIGLIAN-FILHO L, Burnett A, Matak L, Ali O, et al
    vNOTES sentinel nodes removal from a remaining cervix.
    J Gynecol Obstet Hum Reprod. 2026;55:103189.
    PubMed    
    Abstract available

  153. DE CAMPOS MR, Carvalho LHSB, Campos AJR, Cora GR, et al
    Knowledge and Perception of Human Papillomavirus in Quilombola Communities in Northeast Brazil.
    Hisp Health Care Int. 2026;24:172-180.
    PubMed    
    Abstract available

  154. KAYA FM, Ersoz S, Comba C, Demir O, et al
    Comparison of Cytological and/or Histopathological Results of Patients with Single and Multiple HPV Positivity.
    Acta Cytol. 2026;70:393-402.
    PubMed    
    Abstract available

  155. HANSEN J, Maclin BJ, Folmann B, Moller JE, et al
    Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study.
    Acta Obstet Gynecol Scand. 2026 Jul 27:10.1111/aogs.70311.
    PubMed    
    Abstract available

  156. AARNIO R, Ahuja V, Ryen L, Bergengren L, et al
    Balancing diagnostic accuracy and cost in the follow-up of histological low-grade squamous intraepithelial lesions.
    Acta Obstet Gynecol Scand. 2026;105:1871-1878.
    PubMed    
    Abstract available

  157. YILDIZ BE, Koc N
    Cytomorphologic Findings Associated With High-Risk HPV Categories in PAP Smears.
    Diagn Cytopathol. 2026;54:637-643.
    PubMed    
    Abstract available

  158. KONG Y, Cao T, Pan Q, Zhao D, et al
    Basaloid Squamous Cell Carcinoma of the Uterine Cervix: An Often Aggressive Subtype Frequently Underestimated by Cytology.
    Diagn Cytopathol. 2026 May 14. doi: 10.1002/dc.70145.
    PubMed    
    Abstract available

  159. JIANG A, Chen Y, Ma F, Zhang H, et al
    Malignant transformation risk and management dilemmas of atypical lobular endocervical glandular hyperplasia: A retrospective cohort study comparing Peutz-Jeghers syndrome versus sporadic cases.
    Gynecol Oncol. 2026;211:51-58.
    PubMed    
    Abstract available

  160. FENG P, Shi K, Zhao W, Zhang J, et al
    Diagnostic value of FAM19A4/SOX1/PAX1 methylation in non-16/18 high-risk HPV cervical lesions.
    Gynecol Oncol. 2026;211:37-45.
    PubMed    
    Abstract available

  161. ARMAROLI P, Zappa M, Giorgi Rossi P, Carozzi FM, et al
    Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening.
    Int J Cancer. 2026 May 5. doi: 10.1002/ijc.70536.
    PubMed    
    Abstract available

  162. MOUFARRIJ S, Pareja R, Fletcher A, Wilailak S, et al
    De-escalating radical surgery for select FIGO Stage I cervical cancer.
    Int J Gynaecol Obstet. 2026 Jul 27. doi: 10.1002/ijgo.71230.
    PubMed    
    Abstract available

  163. LANDMAN Y, De Sousa Smith C, Ke S, Roumeliotis M, et al
    Image-guided brachytherapy for locally advanced cervical cancer: clinical outcomes and fistula risk in stage IVA disease.
    Int J Gynecol Cancer. 2026;36:104848.
    PubMed    
    Abstract available

  164. MARTINS JC, Simonsen M, Salim RC, de Azevedo Focchi GR, et al
    Lymphovascular space invasion in cervical cancer: beyond the binary.
    Int J Gynecol Cancer. 2026 Jul 11:104864. doi: 10.1016/j.ijgc.2026.104864.
    PubMed    


  165. CASARIN J, Bianchi T, Torri V, Melazzini MG, et al
    Surgical volume, structural quality, and compliance with European Society of Gynaecological Oncology quality indicators in endometrial and cervical cancer: a regional cross-sectional assessment.
    Int J Gynecol Cancer. 2026;36:104847.
    PubMed    
    Abstract available

  166. EL HAJJ H, Gouy S, Limkin E, Scherier S, et al
    Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?
    Int J Gynecol Cancer. 2026 Jul 15:104874. doi: 10.1016/j.ijgc.2026.104874.
    PubMed    


  167. AHN SH, Bhutta ZA, Na H, Lee HK, et al
    Anticancer effects of tangeretin associated with reactive oxygen species generation, mitochondrial dysfunction and apoptosis in CaSki cells.
    Oncol Rep. 2026;56:166.
    PubMed    
    Abstract available

  168. LONG C, Wang S, Wang Y
    SPP1 promotes cisplatin resistance in cervical cancer by regulating KRAS expression.
    PLoS One. 2026;21:e0353621.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;